Baker Brothers Life Sciences Capital (GP), LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is a 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a 10% Owner in PHARMACYCLICS INC ($PCYC) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and a 10% Owner in Ocera Therapeutics, Inc. ($TZYM).

Address: 667 MADISON AVENUE, 21ST FLOOR NEW YORK US 10065 NY

Companies in which Baker Brothers Life Sciences Capital (GP), LLC is an Insider

ADOLOR CORP

Trading Symbol: ADLR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 03 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ardea Biosciences, Inc./DE

Trading Symbol: IBPI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 4,922,226 shares
Latest Transaction: Feb 03 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AUXILIUM PHARMACEUTICALS INC

Trading Symbol: AUXL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,416,304 shares
Latest Transaction: Aug 03 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 3,841,124 shares
Current Value: $21,779,173
Latest Transaction: Jul 05 2011
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 8,255,421 shares
Current Value: $226,941,523
Latest Transaction: Mar 09 2012
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HERON THERAPEUTICS, INC. /DE/

Trading Symbol: HRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,266,568 shares
Latest Transaction: Jul 05 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 12,430,783 shares
Current Value: $1,469,069,935
Latest Transaction: Jan 17 2012
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ocera Therapeutics, Inc.

Trading Symbol: TZYM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 3,540,015 shares
Latest Transaction: Mar 14 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PHARMACYCLICS INC

Trading Symbol: PCYC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 8,574,445 shares
Latest Transaction: Jan 26 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 15,131,223 shares
Current Value: $919,827,046
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 5,077,676 shares
Latest Transaction: Jan 09 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

VIROPHARMA INC

Trading Symbol: VPHM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 9,840,469 shares
Latest Transaction: Dec 16 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC

Sentiment: All, ADLR, IBPI, AUXL, BCRX, GHDX, HRTX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP3.0134,544103,8223,540,0153.5 M to 3.5 M (+0.99 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP2.9956,294168,2683,505,4713.4 M to 3.5 M (+1.63 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP2.96159,015470,3823,449,1773.3 M to 3.4 M (+4.83 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP2.55572,7371,460,4793,290,1622.7 M to 3.3 M (+21.08 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP2.34327,769766,8482,717,4252.4 M to 2.7 M (+13.72 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP1.8744,46783,1532,389,6562.3 M to 2.4 M (+1.90 %)
Mar 14 2012TZYMOcera Therapeutics ...Baker Brothers Life Sciences C ...10% OwnerBuyP1.8916,32630,7882,345,1892.3 M to 2.3 M (+0.70 %)

View all Baker Brothers Life Sciences Capital (GP), LLC insider transactions.

How Companies Report Insider Transactions

Trading of stock is controlled by the Securities and Exchange Commission (SEC), an agency of the United States federal government. More ...

What Do the Transaction Codes Mean?

Each transaction listed on the Form 4 filing must be marked with a transaction code. Here is a list and description of transaction codes as used and categorized by the SEC. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

Contact us | Follow us on Twitter